Dose-painting IMRT optimization using biological parameters

Acta Oncologica

Volumn 49, Issue 8, 2010, Pages 1374-1384

  Kim, Yusung ^a   Tomé, Wolfgang A ^b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLADDER CANCER; CANCER RADIOTHERAPY; DIAGNOSTIC ACCURACY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RECTUM CANCER; SENSITIVITY AND SPECIFICITY;

HUMANS; LOGISTIC MODELS; NEOPLASMS; POISSON DISTRIBUTION; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 77956596461     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/02841861003767539     Document Type: Article

References (31)

1. Thomlinson RH, Gray LH. The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer 1955;9:539-49.
2. Weichselbaum RR, Beckett MA, Schwartz JL, Dritschilo A. Radioresistant tumor cells are present in head and neck carcinomas that recur after radiotherapy. Int J Radiat Oncol Biol Phys 1988;15:575-9.
3. Tome WA, Fowler JF. Selective boosting of tumor subvolumes. Int J Radiat Oncol Biol Phys 2000;48:593-9.
4. Popple RA, Ove R, Shen S. Tumor control probability for selective boosting of hypoxic subvolumes, including the effect of reoxygenation. Int J Radiat Oncol Biol Phys 2002;54:921-7.
5. Kim Y, Tomé WA. Risk-adaptive optimization: Selective boosting of high-risk tumor subvolumes. Int J Radiat Oncol Biol Phys 2006;66:1528-42.
6. Ling CC, Humm J, Larson S, Amols H, Fuks Z, Leibel S, et al. Towards multidimensional radiotherapy (MD-CRT): Biological imaging and biological conformality. Int J Radiat Oncol Biol Phys 2000;47:551-60.
7. Bentzen SM. Theragnostic imaging for radiation oncology: Dose-painting by numbers. Lancet Oncol 2005;6:112-7.
8. Chao KS, Bosch WR, Mutic S, Lewis JS, Dehdashti F, Mintun MA, et al. A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 2001;49:1171-82.
9. van Lin EN, Futterer JJ, Heijmink SW, van der Vight LP, Hoffmann AL, van Kollenburg P, et al. IMRT boost dose planning on dominant intraprostatic lesions: Gold markerbased three-dimensional fusion of CT with dynamic contrastenhanced and 1H-spectroscopic MRI. Int J Radiat Oncol Biol Phys 2006;65:291-303.
10. Pickett B, Vigneault E, Kurhanewicz J, Verhey L, Roach M. Static field intensity modulation to treat a dominant intra-prostatic lesion to 90 Gy compared to seven field 3-dimensional radiotherapy. Int J Radiat Oncol Biol Phys 1999;44:921-9.
11. Xia P, Pickett B, Vigneault E, Verhey LJ, Roach M, 3rd. Forward or inversely planned segmental multileaf collimator IMRT and sequential tomotherapy to treat multiple dominant intraprostatic lesions of prostate cancer to 90 Gy. Int J Radiat Oncol Biol Phys 2001;51:244-54.
12. Sanchez-Nieto B, Nahum AE. The delta-TCP concept: A clinically useful measure of tumor control probability. Int J Radiat Oncol Biol Phys 1999;44:369-80.
13. Sanchez-Nieto B, Nahum AE, Dearnaley DP. Individualization of dose prescription based on normal-tissue dosevolume and radiosensitivity data. Int J Radiat Oncol Biol Phys 2001;49:487-99.
14. Kallman P, Lind BK, Brahme A. An algorithm for maximizing the probability of complication-free tumour control in radiation therapy. Phys Med Biol 1992;37:871-90.
15. Sodertrom S, Brahme A. Optimization of the dose delivery in a few field techniques using radiobiological objective functions. Med Phys 1993;20:1201-10.
16. Brahme A, Agren AK. Optimal dose distribution for eradication of heterogeneous tumours. Acta Oncol 1987;26:377-85.
17. Agren A, Brahme A, Turesson I. Optimization of uncomplicated control for head and neck tumors. Int J Radiat Oncol Biol Phys 1990;19:1077-85.
18. Kim Y, Tome WA. Is it beneficial to selectively boost high-risk tumor subvolumes? A comparison of selectively boosting high-risk tumor subvolumes versus homogeneous dose escalation of the entire tumor based on equivalent EUD plans. Acta Oncol 2008;47:906-16.
19. Kim Y, Tome WA. On the impact of functional imaging accuracy on selective boosting IMRT. Physica Medica 2009;25:12-24.
20. Levegrun S, Jackson A, Zelefsky MJ, Venkatraman ES, Skwarchuk MW, Schlegel W, et al. Risk group dependence of dose-response for biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer. Radiother Oncol 2002;63:11-26.
21. Lyman JT. Complication probability as assessed from dosevolume histograms. Radiat Res Suppl 1985;8: S13-S19.
22. Kutcher GJ, Burman C. Calculation of complication probability factors for non-uniform normal tissue irradiation: The effective volume method. Int J Radiat Oncol Biol Phys 1989;16:1623-30.
23. Tome WA, Fenwick JD. Analysis of radiation-induced liver disease using the Lyman NTCP model: In regard to Dawson et al. IJROBP 2002;53:810-21.
24. Int J Radiat Oncol Biol Phys 2004;58:1318-9; author reply 1319-20.
25. Romeijn HE, Dempsey JF, Li JG. A unifying framework for multi-criteria fluence map optimization models. Phys Med Biol 2004;49:1991-2013.
26. Niemierko A. Reporting and analyzing dose distributions: A concept of equivalent uniform dose. Med Phys 1997;24:103-10.
27. Zelefsky MJ, Fuks Z, Leibel SA. Intensity-modulated radiation therapy for prostate cancer. Semin Radiat Oncol 2002;12:229-37.
28. Rancati T, Fiorino C, Gagliardi G, Cattaneo GM, Sanguineti G, Borca VC, et al. Fitting late rectal bleeding data using different NTCP models: Results from an Italian multi-centric study (AIROPROS0101). Radiother Oncol 2004;73:21-32.
29. Burman C, Kutcher GJ, Emami B, Goitein M. Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys 1991;21:123-35.
30. Kim Y, Tomé WA. On voxel based iso-tumour-control probability and iso-complication maps for selective boosting and selective avoidance intensity-modulated radiotherapy. Imaging Decisions MRI 2008;12:42-52.
31. Munro TR, Gilbert CW. The relation between tumour lethal doses and the radiosensitivity of tumour cells. Br J Radiol 1961;34:246-51.